A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-05-0440
Full Text
Open PDFAbstract
Available in full text
Date
September 15, 2005
Authors
Publisher
American Association for Cancer Research (AACR)